Carotid ArteryPRIMENCT07877480
Predicting High-Risk Carotid Plaque: Integrating radioMics and biomEchanics
A study testing Radiomic features analysis in people with Carotid Artery and Carotid Arteriosclerosis, run by Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico at 1 site in Italy.
Trial summary
Non-pharmacological interventional study for the development of a predictive model aimed at identifying unstable carotid plaques in asymptomatic patients at first diagnosis, with the use of biological material and prospective-retrospective data collection Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Carotid Artery, Carotid Arteriosclerosis
- What is being tested?
- Radiomic features analysis
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 420 participants
- Where
- 1 siteItaly
- Study dates
- 1 Sep 2025to 30 Dec 2026
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Patients ≥ 18 years of age;
- Affected by significant carotid atherosclerosis, whether symptomatic or asymptomatic (stenosis ≥ 70% according to ECST criteria).
- Candidates for carotid ATE surgery. The criteria provided by the SICVE and ESVS guidelines will be followed for indications for surgery;
- Preoperative imaging available;
Who cannot join
- Patients who have undergone previous carotid endarterectomy (ipsilateral to the affected side);
- Patients who have undergone previous neck surgery involving cervical lymph node dissection;
- Patients who have undergone previous neck radiation therapy;
- Lack of preoperative imaging;
- Patients unable to sign informed consent.
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
Italy1 site, 1 recruiting
- Recruiting
Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico
Milan
MAURIZIO DOMANIN, MD, +390255032438, maurizio.domanin@unimi.it
About this study
Non-pharmacological interventional study for the development of a predictive model aimed at identifying unstable carotid plaques in asymptomatic patients at first diagnosis, with the use of biological material and prospective-retrospective data collection
Read the detailed description
Stroke is a leading cause of mortality and morbidity globally, accounting for 12 million cases worldwide in 2019 and a global cost of $891 billion in 2017. One of the main causes of stroke is the rupture of atheromatous plaque in the carotid artery. For this reason, identifying and studying plaques is essential to preventing stroke and cerebrovascular events.
European guidelines recommend risk stratification strategies for carotid plaques based on the degree of stenosis they cause and the assessment, through radiological imaging, of their core characteristics. However, this stratification alone is still not enough. In recent years, scientific research has succeeded in identifying additional markers of instability in the morphological and compositional characteristics of plaques based on imagery.
Finally, radiomics, a new field of high-throughput extraction of quantitative features observable in radiological images, has demonstrated promising results in recognizing and stratifying unstable carotid plaques.
The overall aim of the study is to create a predictive model that aims to identify unstable plaques in asymptomatic patients at initial diagnosis. Currently, the most effective objective method for assessing plaque instability is histopathological analysis, but this is only available after surgery. Therefore, it is crucial to have a noninvasive predictive model for identifying the risk of cerebrovascular accidents in asymptomatic patients.
Specifically, the primary objective is to identify carotid plaque instability by extracting radiomic markers belonging to the "shape and size" (26 shape and size features), "first-order statistics" (19 statistical features), and "textural" (75 texture features) classes from each CTA image. A further objective will be the calculation of mechanical markers (von Mises stress, maximum principal stress, ultimate stress, and thickness) capable of identifying carotid plaque instability in patients with carotid stenosis and candidates for carotid artery stenosis surgical removal.
The study will involve patients attending the Foundation's Vascular Surgery Unit and candidates for carotid artery stenosis. Two specific phases are planned. The first phase will be retrospective and will involve the retrieval of clinical and imaging data to activate machine learning for the analysis of radiomics data in combination with clinical data. Preoperative CT images and perioperative clinical data will be analyzed for training and preliminary development of a machine learning model based on radiomics, clinical, and biomechanical data, calculated from structural and fluid dynamics numerical simulations. Patient-specific preoperative CT images will be segmented using 2D convolutional neural networks (CNNs). The resulting 3D models of vessels and plaques will be used for structural and fluid dynamic simulations and radiomics analysis.
In the second prospective phase, patients will be enrolled consecutively, according to the SOC's indication for surgery. After obtaining written informed consent, the inclusion/exclusion criteria will be evaluated and each patient will be assigned a progressive identification code. Preoperative clinical and imaging (CT) data will be collected. The prospectively enrolled patients will undergo the same procedure (carotid TEA), according to the protocols and standards proposed by the European Society of Vascular Surgery (ESVS) and adopted in common clinical practice by our SC.
At the end of the TEA procedure, in addition to collecting pre- and post-operative clinical data, histopathological and biomechanical analysis of the surgically removed plaque, which is usually not analyzed and disposed of, will be performed. The results will be used to prepare and validate the virtual predictive model. The surgeon will send the removed material, in alternating sequence, once for histology and once for mechanical testing. Subsequently, numerical strategies will be adopted to calculate the biomechanics of carotid arteries affected by the presence of plaque. In addition to these numerical approaches, a machine learning algorithm will be used to couple the previously identified variables (i.e., morphological, histological, radiomic, and biomechanical) to identify markers capable of identifying unstable plaques.
Finally, 3D printing will be used to produce anatomical and functional models of the segmented geometries of patients undergoing TEA. These prints will be inserted into a hydraulic circuit capable of reproducing physiopathological flow and pressure conditions. This strategy will be used to validate the results from the structural and fluid dynamic simulations in a fully controlled environment in terms of postoperative geometric conformation (postoperative diameters achieved by the anatomy) and flow distribution at the fluid dynamic level.
- Conditions
- Carotid Artery, Carotid Arteriosclerosis
- Being tested
- Radiomic features analysis
- Keywords
- carotid endarterectomy, Carotid Artery Disease
- Medical subject headings
- Carotid Artery Diseases
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Radiomic features analysisDiagnostic test
Identification of carotid plaque instability by extracting radiomic markers belonging to the "shape and size" (26 shape and size features), "first order statistics" (19 statistical features) and "textural" (75 texture features) classes from each CTA image
| Study group | Role | What they receive |
|---|---|---|
| Radiomic Analysis | Other | Not described Receives: Diagnostic Test: Radiomic features analysis |
What is being measured
The primary outcome is the main question the study is designed to answer.
Radiomic markers
Identification form CT scan images of a radiomic marker predictive of plaque instability, with an AUC ≥ 0.85.
Measured: at enrollment
Secondary outcomes (1)
Plaque mechanical markers
Measurement of the Von Mises stress absorbed by the plate in MPa
Measured: 24 hours post-op
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted16 Oct 2026
- Study start1 Sep 2025
- Primary completion30 Sep 2026
- Study completion30 Dec 2026 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Carotid ArteryStudies of the same condition, open and under way.
- More trials run by Fondazione IRCCS Ca' Granda, Ospedale Maggiore PoliclinicoThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Diagnosis
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Enrolment
- 420 participants (estimated)
Sponsor and investigators
- Sponsor type
- University, hospital or other
- Collaborators
- University of Pavia
- Responsible party
- Principal investigator, Maurizio Domanin, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07877480
- Sponsor's protocol ID
- 6266
- Acronym
- PRIME
- Status last verified
- Oct 2026
- First submitted
- 2 Oct 2026
- Last updated
- 16 Oct 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 16 Oct 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Predicting High-Risk Carotid Plaque: Integrating radioMics and biomEchanics
- ClinicalTrials.gov ID
- NCT07877480
- Acronym / sponsor ID
- PRIME / 6266
- Conditions
- Carotid Artery, Carotid Arteriosclerosis
- Keywords
- carotid endarterectomy, Carotid Artery Disease
- Study type
- Interventional
- Recruitment status
- Recruiting
- Enrolment
- 420 participants (estimated)
- Lead sponsor
- Fondazione IRCCS Ca' Granda, Ospedale Maggiore PoliclinicoUniversity, hospital or other
- Collaborators
- University of Pavia
- Study start
- 1 Sep 2025 (actual)
- Primary completion
- 30 Sep 2026 (actual)
- Study completion
- 30 Dec 2026 (estimated)
- First posted
- 16 Oct 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Non-pharmacological interventional study for the development of a predictive model aimed at identifying unstable carotid plaques in asymptomatic patients at first diagnosis, with the use of biological material and prospective-retrospective data collection
Detailed description
Stroke is a leading cause of mortality and morbidity globally, accounting for 12 million cases worldwide in 2019 and a global cost of $891 billion in 2017. One of the main causes of stroke is the rupture of atheromatous plaque in the carotid artery. For this reason, identifying and studying plaques is essential to preventing stroke and cerebrovascular events.
European guidelines recommend risk stratification strategies for carotid plaques based on the degree of stenosis they cause and the assessment, through radiological imaging, of their core characteristics. However, this stratification alone is still not enough. In recent years, scientific research has succeeded in identifying additional markers of instability in the morphological and compositional characteristics of plaques based on imagery.
Finally, radiomics, a new field of high-throughput extraction of quantitative features observable in radiological images, has demonstrated promising results in recognizing and stratifying unstable carotid plaques.
The overall aim of the study is to create a predictive model that aims to identify unstable plaques in asymptomatic patients at initial diagnosis. Currently, the most effective objective method for assessing plaque instability is histopathological analysis, but this is only available after surgery. Therefore, it is crucial to have a noninvasive predictive model for identifying the risk of cerebrovascular accidents in asymptomatic patients.
Specifically, the primary objective is to identify carotid plaque instability by extracting radiomic markers belonging to the "shape and size" (26 shape and size features), "first-order statistics" (19 statistical features), and "textural" (75 texture features) classes from each CTA image. A further objective will be the calculation of mechanical markers (von Mises stress, maximum principal stress, ultimate stress, and thickness) capable of identifying carotid plaque instability in patients with carotid stenosis and candidates for carotid artery stenosis surgical removal.
The study will involve patients attending the Foundation's Vascular Surgery Unit and candidates for carotid artery stenosis. Two specific phases are planned. The first phase will be retrospective and will involve the retrieval of clinical and imaging data to activate machine learning for the analysis of radiomics data in combination with clinical data. Preoperative CT images and perioperative clinical data will be analyzed for training and preliminary development of a machine learning model based on radiomics, clinical, and biomechanical data, calculated from structural and fluid dynamics numerical simulations. Patient-specific preoperative CT images will be segmented using 2D convolutional neural networks (CNNs). The resulting 3D models of vessels and plaques will be used for structural and fluid dynamic simulations and radiomics analysis.
In the second prospective phase, patients will be enrolled consecutively, according to the SOC's indication for surgery. After obtaining written informed consent, the inclusion/exclusion criteria will be evaluated and each patient will be assigned a progressive identification code. Preoperative clinical and imaging (CT) data will be collected. The prospectively enrolled patients will undergo the same procedure (carotid TEA), according to the protocols and standards proposed by the European Society of Vascular Surgery (ESVS) and adopted in common clinical practice by our SC.
At the end of the TEA procedure, in addition to collecting pre- and post-operative clinical data, histopathological and biomechanical analysis of the surgically removed plaque, which is usually not analyzed and disposed of, will be performed. The results will be used to prepare and validate the virtual predictive model. The surgeon will send the removed material, in alternating sequence, once for histology and once for mechanical testing. Subsequently, numerical strategies will be adopted to calculate the biomechanics of carotid arteries affected by the presence of plaque. In addition to these numerical approaches, a machine learning algorithm will be used to couple the previously identified variables (i.e., morphological, histological, radiomic, and biomechanical) to identify markers capable of identifying unstable plaques.
Finally, 3D printing will be used to produce anatomical and functional models of the segmented geometries of patients undergoing TEA. These prints will be inserted into a hydraulic circuit capable of reproducing physiopathological flow and pressure conditions. This strategy will be used to validate the results from the structural and fluid dynamic simulations in a fully controlled environment in terms of postoperative geometric conformation (postoperative diameters achieved by the anatomy) and flow distribution at the fluid dynamic level.
Study design
- Primary purpose
- Diagnosis
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Radiomic Analysis | Other | Diagnostic Test: Radiomic features analysis |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (4 listed)
- Patients ≥ 18 years of age;
- Affected by significant carotid atherosclerosis, whether symptomatic or asymptomatic (stenosis ≥ 70% according to ECST criteria).
- Candidates for carotid ATE surgery. The criteria provided by the SICVE and ESVS guidelines will be followed for indications for surgery;
- Preoperative imaging available;
Key exclusion criteria (5 listed)
- Patients who have undergone previous carotid endarterectomy (ipsilateral to the affected side);
- Patients who have undergone previous neck surgery involving cervical lymph node dissection;
- Patients who have undergone previous neck radiation therapy;
- Lack of preoperative imaging;
- Patients unable to sign informed consent.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Radiomic features analysisIdentification of carotid plaque instability by extracting radiomic markers belonging to the "shape and size" (26 shape and size features), "first order statistics" (19 statistical features) and "textural" (75 texture features) classes from each CTA image | Diagnostic test | Radiomic Analysis |
Primary outcome
Radiomic markers
Time frame: at enrollment
Identification form CT scan images of a radiomic marker predictive of plaque instability, with an AUC ≥ 0.85.
1 secondary outcome
Plaque mechanical markers
Time frame: 24 hours post-op
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 16 Oct 2026.
Related trials for Carotid Artery
Not yet recruitingObservational study
CAROTID DOPPLER AND CEREBRAL OXIMERY IN POST CARDIAC ARREST ICU PATIENTS
Cardiac Arrest (CA), Carotid Doppler
Active, not recruitingObservational study
Symptomatic Carotid Outcomes Registry
Carotid Stenosis, Ischemic Stroke
RecruitingObservational study
Estimated Risk of Preeclampsia in the First Trimester and Its Association With Subclinical Atherosclerosis and Cardiovascular Risk in Women With Type 1 Diabetes
Type 1 Diabetes, Preeclampsia
Recruiting
Familial Form of Carotid Web: a Doppler Ultrasound Study
Carotid Web
Not yet recruitingObservational study
PET-MR Imaging of Natriuretic Peptide Receptor C (NPR-C) in Carotid Atherosclerosis With 64Cu-NODAGA-CANF (Multisite)
Carotid Atherosclerosis, Carotid Artery Stenosis Asymptomatic
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico
Milan, Italy
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Radiomic features analysis in people with Carotid Artery and Carotid Arteriosclerosis, run by Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico at 1 site in Italy.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 16 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Italy. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Each site lists its own contact: choose the nearest one under Trial locations. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Radiomic markers (time frame: at enrollment). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 16 Oct 2026.